Founder and Sr. VP of RandD
Dr. Jon Faiz Kayyem, Ph.D., is serving as Senior Vice President Research and Development of GenMark Diagnostics Inc. Jon Faiz Kayyem, Ph.D. has served as Senior Vice President, Research and Development since June 2013. Dr. Kayyem previously served as the Companys Chief Scientific Officer from August 2010 to June 2013. Dr. Kayyem served as President and Chief Executive Officer of the Company from May 2010 to August 2010. From August 2009 to May 2010, Dr. Kayyem served as President and Chief Executive Officer of Osmetech plc and Chairman of the board of directors of Osmetech plc from January 2009 to August 2009. Dr. Kayyem attended Yale University and received a combined M.S. and B.S. in Molecular Biophysics and Biochemistry in 1985. Dr. Kayyem received his Ph.D. in Molecular Biology in 1991 from The California Institute of Technology
Age: 52 Founder Since 2013 Ph.DKayyem remained at Caltech as a Senior Research Fellow until 1995, when he founded Clinical Micro Sensors to commercialize technical innovations he developed while at Caltech. In 2000, Clinical Micro Sensors was sold to Motorola, Inc., and subsequently purchased by Osmetech plc in 2005. In 2004, Dr. Kayyem left Clinical Micro Sensors and cofounded the biotechnology fund management company, Efficacy Capital Limited, where he served as managing partner until September 2009.
Management EfficiencyThe company has return on total asset (ROA) of (36.85) % which means that it has lost $36.85 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE) of (113.93) % meaning that it created substantial loss on money invested by shareholders.
Entity SummaryGenMark Diagnostics, Inc., a molecular diagnostics company, develops and commercializes molecular tests based on its proprietary eSensor electrochemical detection technology. GenMark Diagnostics, Inc. is headquartered in Carlsbad, California. GenMark Diagnostics operates under Medical Appliances Equipment classification in USA and traded on NASDAQ General Markets. It employs 517 people.GenMark Diagnostics (GNMK) is traded on NASDAQ General Markets in USA. It is located in CALIFORNIA, U.S.A and employs 517 people. GenMark Diagnostics is listed under Medical Equipment category by Fama And French industry classification.
GenMark Diagnostics Leadership Team
Stock Performance Indicators
Crypto Portfolio Optimizer
Optimize portfolio of digital coins and token across multiple currency and exchanges
|Hide View All Next||Launch Crypto Portfolio Optimizer|
Please also check Risk vs Return Analysis. Please also try Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.